SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Research Expenditures and the Discovery of New Drugs
5 references·14 citing·38 second hop
Research Expenditures and the Discovery of New Drugs (1987)Research Expenditures and the Discovery o…Econometric Models for Count Data with an Application to the Patents-R & D Relationship (1984)Econometric Models for Count …Limited-dependent and qualitative variables in econometrics (1983)Limited-dependent and qualita…Preemptive Patenting and the Persistence of Monopoly (1982)Preemptive Patenting and the …An Evaluation of Consumer Protection Legislation: The 1962 Drug Amendments (1973)An Evaluation of Consumer Pro…Research and Technical Change in the Pharmaceutical Industry (1965)Research and Technical Change…Information arrival, delay, and clustering in financial markets with dynamic freeriding (2020)Information arrival, delay, a…Patents vs publications and R&D: three sides of the same coin? Panel Smooth Transition Regression (PSTR) for OECD and BRICS countries (2018)Patents vs publications and R…Who rides the tide of regionalization: Examining the effect of the China-ASEAN Free Trade Area on the exports of Chinese firms (2017)Who rides the tide of regiona…Licensee technological potential and exclusive rights in international licensing: A multilevel model (2013)Licensee technological potent…The relation between firm size and R&D productivity in different technological regimes (2012)The relation between firm siz…Re-examine the relationship between patents and Tobin’s q (2011)Re-examine the relationship b…Enhancing Research Productivity through the Market for Technology (2008)Enhancing Research Productivi…The Impact of Patenting on New Product Introductions in the Pharmaceutical Industry (2007)The Impact of Patenting on Ne…Does R&D performance decline with firm size?—A re-examination in terms of elasticity (2005)Does R&D performance decline …Research Productivity in the Japanese Pharmaceutical Industry: Economies of Scale, Economies of Scope and Spillovers (2004)Research Productivity in the …R&D productivity and firm size: a nonlinear examination (2004)R&D productivity and firm siz…ORGANIZING FOR TECHNOLOGICAL INNOVATION IN THE U.S. PHARMACEUTICAL INDUSTRY (2004)ORGANIZING FOR TECHNOLOGICAL …Impact of mergers & acquisitions on research productivity within the pharmaceutical industry (2004)Impact of mergers & acquisiti…R&D Costs, Innovative Output and Firm Size in the Pharmaceutical Industry (1995)R&D Costs, Innovative Output …Cost of innovation in the pharmaceutical industry (1991)Brand Loyalty, Entry, and Price Competition in Pharmaceuticals after the 1984 Drug Act (1992)Scale, Scope, and Spillovers: The Determinants of Research Productivity in Drug Discovery (1996)The impact of ESG on firm value: The moderating role of cash holdings (2025)Absorptive Capacity: A New Perspective on Learning and Innovation (1990)Some Tests of Specification for Panel Data: Monte Carlo Evidence and an Application to Employment Equations (1991)The Theory of Economic Development (2003)Fostering product innovation: Differences between new ventures and established firms (2015)Outcomes of Management Innovation: An Empirical Analysis in the Services Industry (2016)The Impact of Digital Marketing Innovation on Firm Performance: Mediation by Marketing Capability and Moderation by Firm Size (2023)A resource‐based view of the firm (1984)Firm Resources and Sustained Competitive Advantage (1991)Firm resources and sustained competitive advantage (2004)Culture's Consequences: International Differences in Work-Related Values (1981)Culture's Consequences: International Differences in Work-Related Values. (1983)Third Parties and Contract Design: The Case of Contracts for Technology Transfer (2015)Diaspora ownership and international technology licensing by emerging market firms (2020)Conditional logit analysis of qualitative choice behavior (1972)On the Pooling of Time Series and Cross Section Data (1978)Specification Tests in Econometrics (1978)Aging, Obsolescence, and Organizational Innovation (2000)Simple solutions to the initial conditions problem in dynamic, nonlinear panel data models with unobserved heterogeneity (2005)Competition and Innovation: An Inverted U Relationship (2008)First-mover advantages (1988)Entry, Exit, Growth, and Innovation over the Product Life Cycle (1996)Dynamic capabilities and strategic management (1997)Innovation and Peripherality: An Empirical Comparative Study of SMEs in Six European Union Member Countries (2008)The interaction effect of strategic orientations on new product performance in the high-tech industry: A nonlinear model (2010)International collaboration and innovation in professional and technological knowledge-intensive services (2018)The Transitional Gains Trap (1975)The machinery of freedom: guide to a radical capitalism (1990)The impact of price regulation on the launch delay of new drugs—evidence from twenty‐five major markets in the 1990s (2004)Econometric Analysis of Cross Section and Panel Data (2001)Does Foreign Direct Investment Increase the Productivity of Domestic Firms? In Search of Spillovers Through Backward Linkages (2004)Introductory Econometrics for Finance (2008)Research and Development in Industrial Growth (1971)Research and Development Costs and Returns: The U.S. Pharmaceutical Industry (1972)The Choice of Strategic Alternatives Under Increasing Regulation in High Technology Companies (1984)
this work references cited by second hop

References

  • 1983Limited-dependent and qualitative variables in econometrics13,257 cited
  • 1984Econometric Models for Count Data with an Application to the Patents-R & D Relationship3,391 cited
  • 1982Preemptive Patenting and the Persistence of Monopoly1,351 cited
  • 1973An Evaluation of Consumer Protection Legislation: The 1962 Drug Amendments369 cited
  • 1965Research and Technical Change in the Pharmaceutical Industry138 cited

Cited by

  • 2012The relation between firm size and R&D productivity in different technological regimes106 cited
  • 2005Does R&D performance decline with firm size?—A re-examination in terms of elasticity87 cited
  • 1995R&D Costs, Innovative Output and Firm Size in the Pharmaceutical Industry68 cited
  • 2004R&D productivity and firm size: a nonlinear examination62 cited
  • 2013Licensee technological potential and exclusive rights in international licensing: A multilevel model37 cited
  • 2004ORGANIZING FOR TECHNOLOGICAL INNOVATION IN THE U.S. PHARMACEUTICAL INDUSTRY37 cited
  • 2020Information arrival, delay, and clustering in financial markets with dynamic freeriding29 cited
  • 2017Who rides the tide of regionalization: Examining the effect of the China-ASEAN Free Trade Area on the exports of Chinese firms29 cited
  • 2004Impact of mergers & acquisitions on research productivity within the pharmaceutical industry

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

27 cited
  • 2004Research Productivity in the Japanese Pharmaceutical Industry: Economies of Scale, Economies of Scope and Spillovers13 cited
  • 2018Patents vs publications and R&D: three sides of the same coin? Panel Smooth Transition Regression (PSTR) for OECD and BRICS countries12 cited
  • 2007The Impact of Patenting on New Product Introductions in the Pharmaceutical Industry11 cited
  • 2011Re-examine the relationship between patents and Tobin’s q9 cited
  • 2008Enhancing Research Productivity through the Market for Technology6 cited